SANUWAVE Health, Inc.
SNWV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 60% | 21.8% | 28.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.2% | 70.4% | 74.1% | 61.7% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -50.8% | -44.9% | 28.6% | -145.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -96.1% | -126.5% | -61.5% | -209.5% |
| EPS Diluted | -7.03 | -12.19 | -7.02 | -19.72 |
| % Growth | 42.3% | -73.6% | 64.4% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |